Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Munziq is a traditional Uighur (and Unani) polyherbal formulation used as a maturative agent to prepare abnormal humors for elimination from the body. In the treatment of vitiligo (Kalbe), it is specifically used to ripen the 'Sauda' (black bile) humor, which is believed to be imbalanced in this condition. The formulation typically consists of various botanical ingredients, including *Anchusa italica*, *Glycyrrhiza glabra*, and *Foeniculum vulgare*, which are thought to provide antioxidant and immunomodulatory effects. Munziq is usually administered as part of a sequential regimen followed by a purgative (Musili) to promote the repigmentation of skin lesions. Clinical research, such as retrospective studies conducted by the Xinjiang Kashi Region Uighur Medicine Hospital, evaluates the effectiveness of this traditional regimen in real-world settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Munziq.